5FW-27955-95636
3 vaccinations
3 coded responses
29 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 760 / TX
- Registered
- 2021-03-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-06
Registered in v-safe
-
2021-03-06
Dose 1 — Janssen/Johnson & Johnson
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-20
- 2021-03-29
- 2021-04-03
- 2021-04-10
-
2021-04-17
Survey response — day 42, single doseMedDRA: Nasopharyngitis, Rhinorrhoea — Feeling: GoodFree text: A cold with some nasal dischargeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-05
- 2021-09-04
-
2021-10-25
Dose 2 — Moderna
- 2021-10-31
- 2021-11-03
- 2021-11-08
- 2021-11-15
- 2021-11-22
- 2021-12-01
- 2021-12-06
- 2022-01-26
-
2022-04-25
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: PregnantMedDRA releases: 2024-11 · check-in free text available
-
2022-09-13
Dose 3 — ModernaCo-administered: Flu
-
2022-09-30
Survey response — day 14, dose 3MedDRA: Gestational diabetes, Office visit — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Diagnosis of gestational diabetes · Healthcare visit (other): SpecialistMedDRA releases: 2024-11 · check-in free text available
-
2022-09-30
Report sent to call center — day 14, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2022-10-04
-
2022-10-04
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-10-11
- 2022-12-13
- 2023-03-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-06 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-25 | Moderna | No |
| 3 | 2022-09-13 | Moderna | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-09-30 | Successful 2022-10-04 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 7 — day 42, single dose
Symptoms: A cold with some nasal discharge
Release 11 — 6 months, dose 2
Symptoms: Pregnant
Release 12 — day 14, dose 3
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Gestational diabetes | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release